Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

British businesses worth more than half a trillion pounds in total could quit the stock market, analysts have warned.

Find the best undervalued stocks to buy in 2025. Learn which top global companies offer strong potential for smart investing and dividend growth.

Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...

Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...